Romed Klinikum Rosenheim — Clinical Trial Site

25 Registered trials

14 Currently recruiting

Organisation

Romed Klinikum Rosenheim

Location

Rosenheim, Germany

Identifier

ORG-100046330

Address

Ellmaierstrasse 23, Ost, 83022, Germany

Departments

"RoMed Klinikum Rosenheim Medizinische Klinik III"
1904: Med. Clinic III
Abteilung Gynaekologie und Geburtshilfe
Chirurgie
Clinic for Gynecology and Obstetrics
Department of Internal Medicine II
Gynecology and Obstetrics
Innere Medizin, Internistische Onkologie
Internistische Onkologie und Hämatologie
Klinik für Anästhesiologie und Operative Intensivmedizin
Klinik für Gynäkologie und Geburtshilfe
Lungenfacharztpraxis / Pneumologische Ambulanz
Medizinische Klinik 3
Medizinische Klinik II
Medizinische Klinik III
N/A
Onkologische Tagesklinik
Pneumologische Ambulanz
Romed Klinikum Rosenheim
Studienzentrum Med 3

Clinical trials at this site (25)

Search interface

A Study of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50% Pending

2025-523586-18-00 Non-Small Cell Lung Cancer 5
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA). Recruiting

2023-507031-38-00 Severe viral lung infections 5 2023-01-09
A study to investigate the effect of AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease Recruiting

2025-520473-40-00 Moderate to Very Severe Chronic Obstructive Pulmonary D 4 2025-09-29
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmona… Recruiting

2024-517458-90-00 Chronic obstructive pulmonary disease (COPD) 5 2025-06-06
SURVIVE HERoes – A randomized Secondary Adjuvant Treatment Intervention study comparing Trastuzumab-Deruxtecan to SOC therapy in eBC Patient… Recruiting

2024-516173-76-01 HER2-positive or HER2-low (incl. ultra-low) early breas 5 2025-04-22
A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects … Recruiting

2023-504904-26-00 Progressive Pulmonary Fibrosis 5 2025-04-07
Pre-Operative Treatment in rEseCTable cOlon canceR (PROTECTOR/FIRE-10; AIO-KRK-0620; IAG-VO-0323) Prospective, randomized, open-label, multi… Recruiting

2023-508076-11-00 Colon cancer staged T3-4 and/or nodal positive by CT an 5 2025-04-01
A Placebo-Controlled Study of Inhaled Pirfenidone in Progressive Pulmonary Fibrosis Recruiting

2023-508429-29-00 Progressive Pulmonary Fibrosis 4 2024-09-26
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered-Dose Inhaler on Cardiopulmonary Outcomes in C… Recruiting

2023-507407-59-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2024-07-04
A study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet Recruiting

2023-506150-21-00 Celiac Disease 4 2024-05-29
Effect of acyclovir therapy on the outcome of ventilated patients with lower respiratory tract infection and detection of herpes simplex vir… Recruiting

2023-504322-19-00 Patients in the intensive care unit on ventilation with 5 2024-01-10
TransNiDeG Recruiting

2023-503349-71-00 Pancreatodudoenectomy 4 2023-10-30
MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancer Recruiting

2024-511219-78-00 epithelial ovarian cancer 5 2023-02-28
CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCE… Recruiting

2022-500764-35-00 Patients with advanced HER2-negative, hormone receptor 6 2022-10-13
Post-resection/ ablation chemotherapy in patients with metastatic colorectal cancer (FIRE-9 - PORT / AIO-KRK-0418). Prospective, randomized,… Recruiting

2024-512174-10-00 metastatic colorectal cancer 5 2021-11-11
A 26-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Efficacy, Safety, and Tolerability of Axatilimab… Ended

2022-502954-15-00 Idiopathic pulmonary fibrosis 4 2024-06-21
A study to investigate long-term safety and tolerability of itepekimab in participants with COPD Ended

2023-508085-15-00 Chronic Obstructive Pulmonary Disease 5 2024-05-15
Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease Ended

2023-504471-25-00 Fibrotic Lung Disease 5 2024-03-01
Clinical trial comparing Trastuzumab Deruxtecan with Trastuzumab Emtansine in high-risk HER2-positive patients with residual breast cancer f… Ended

2023-507961-24-00 High-Risk HER2-Positive Breast Cancer 5 2021-04-19
RACE-trial: Neoadjuvant Radiochemotherapy versus Chemotherapy for Patients with Locally Advanced, Potentially Resectable Adenocarcinoma of t… Ended

2024-516271-32-00 Adenocarcinoma of the gastroesophageal junction (AEG ty 5 2020-06-03
A study to compare efficacy, safety, and immune response of GME751 and EU-authorized Keytruda in adult participants with untreated metastati… Ended

2023-506882-70-00 Non-small-cell lung cancer 5 2024-08-16
A Study to Evaluate the Efficacy and Safety of Astegolimab in Patients with Chronic Obstructive Pulmonary Disease Ended

2022-502234-70-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2023-07-14
A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects … Ended

2024-514761-19-00 Idiopathic Pulmonary Fibrosis 5 2023-01-25
Study to assess the efficacy, safety, and tolerability of SAR440340/REGN3500/itepekimab in chronic obstructive pulmonary disease (COPD) (AER… Ended

2024-512012-21-00 Chronic Obstructive Pulmonary Disease 5 2021-04-08